On Jan. 26, 2009, Pfizer and Wyeth entered into a definitive merger agreement valued at approximately $68 billion. Analysts from AMR Research and Argus Research companies discuss the details of the possible transaction.
The acquisition is expected to enhance Oracle Enterprise Manager with extensive capabilities for managing application configurations across IT environments.